RxDoctor Payments Data

Andrew Lake, MD

Gastroenterology · Gainesville, GANPI 1821224809

Payments from drug & device makers

$8,669in general payments, 2019–2025

Across 502 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$999
  • Johnson & Johnson$687
  • Takeda Pharmaceuticals U.S.A., Inc.$519
  • Gilead$503
  • Intercept Pharmaceuticals, Inc.$440
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$8,45698%
  • Education$2132%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,669 in reported general payments places this provider in the 70th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Medicare billing

Part B allowed, 2024
$248,610
Medicare patients
582
Services billed
5,925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ZenpepLipase/Protease/Amylase14$65,713
XifaxanRifaximin17$47,859
LinzessLinaclotide61$41,792
SutabSod Sulf/Pot Chloride/Mag Sulf77$12,295
MotegrityPrucalopride Succinate13$6,769
Sucralfate119$4,335
Omeprazole362$3,920
Mesalamine ErMesalamine14$3,787
ClenpiqSod Picosulf/Mag Ox/Citric Ac16$2,705
Budesonide DrBudesonide26$2,484
Mesalamine18$2,436
Lubiprostone13$2,329
Colesevelam Hcl12$2,321
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates34$2,225
Budesonide EcBudesonide11$2,076

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Aimmune Therapeutics, Inc.Zenpep$32$65,71314 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$999$47,85917 claims
AbbVieLinzess$1,920$41,79261 claims
Braintree Laboratories, Inc.Sutab$17$12,29577 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$519$6,76913 claims
Ferring Pharmaceuticals Inc.Clenpiq$97$2,70516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 492 gastroenterology providers in Georgia.

Other gastroenterology in Gainesville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →